Tremor

Neurology·MeSH: Tremor

8 drugs in development·4 companies·2 clinical trials

Drug Pipeline by Phase

Phase 3(2)

Drug	Company
60 mg ulixacaltamide	Praxis Precision Medicines, Inc. (PRAX)
Ulixacaltamide	Praxis Precision Medicines, Inc. (PRAX)

Phase 2(2)

Drug	Company
JZP385	Jazz Pharmaceuticals plc (JAZZ)
sepranolone	RELMADA THERAPEUTICS, INC. (RLMD)

Preclinical(1)

Drug	Company
SAGE-817	Sage Therapeutics, Inc. (SAGE)

Phase 2/Phase 3(3)

BioSniper tracks 8 drugs in development for Tremor across 4 companies.

There are 2 clinical trials targeting Tremor tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.